Greg Anglin - Concepedia

Concepedia

Author

Greg Anglin

Eli Lilly (United States)

Also Known As

Anglin, Greg, G Anglin, G. Anglin, GREG ANGLIN, Greg Anglin

25

Publications

1.6K

Citations

14

H-Index

9

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (Canada)

GA

About

Greg Anglin is an author at Eli Lilly (United States) specializing in medicine, urology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	435
2	Pharmacology	2	2	389
3	Cell Biology	1	1	46
4	Cancer Therapeutics	1	1	46
5	Lung Cancer	1	1	46

Greg Anglin

×

14

Publications

1.6K

Citations

14

H-Index

	Year	Citations
Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated Analyses Gerald Brock, Chris G. McMahon, K.K. Chen, The Journal of Urology	2002	540
Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial Hartmut Porst, Harin Padma-Nathan, François Giuliano, Urology UrologyErectile DysfunctionMedicineSexual DysfunctionPharmacology	2003	324
Effects of Tadalafil on Erectile Dysfunction in Men With Diabetes Iñigo Sáenz de Tejada, Greg Anglin, James Knight, Diabetes Care	2002	246
Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Shepherd Fa, Abratt Rp, Hana Anderson, PubMed	1997	100
Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase <scp>II</scp> and <scp>III</scp> clinical trials Katherine R. Tuttle, T. D. McKinney, Jaime A. Davidson, Diabetes Obesity and Metabolism	2016	65
Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated Analyses Gerald Brock, Chris G. McMahon, K. K. CHEN, The Journal of Urology UrologyIntegrated AnalysesErectile DysfunctionMedicineSexual Dysfunction	2002	65
Genomic Imprinting in Turner Syndrome: Effects on Response to Growth Hormone and on Risk of Sensorineural Hearing Loss C Hamelin, Greg Anglin, Charmian A. Quigley, The Journal of Clinical Endocrinology & Metabolism	2006	61
The influence of gemcitabine and cisplatin schedule on response and survival in advanced non-small cell lung cancer Frances A. Shepherd, Raymond P. Abratt, Lucio Crinò, Lung Cancer MedicineBronchial NeoplasmCisplatin ScheduleLung CancerRadiation Oncology	2000	46
Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide Michael A. Nauck, Jean‐Louis Frossard, Jamie S. Barkin, Diabetes Care	2017	32
Efficacy and Safety of Oral Tadalafil in the Treatment of Men in Canada with Erectile Dysfunction: A Randomized, Double–Blind, Parallel, Placebo–Controlled Clinical Trial Serge Carrier, Gerald Brock, Peter Pommerville, The Journal of Sexual Medicine	2005	30

Page 1